Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
AstraZeneca
AZN
|
+$810M |
| 2 |
Intuitive Surgical
ISRG
|
+$705M |
| 3 |
S&P Global
SPGI
|
+$439M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$361M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$253M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$605M |
| 2 |
FedEx
FDX
|
+$587M |
| 3 |
Monster Beverage
MNST
|
+$395M |
| 4 |
McDonald's
MCD
|
+$387M |
| 5 |
Booking.com
BKNG
|
+$380M |
Sector Composition
| 1 | Technology | 22.3% |
| 2 | Consumer Discretionary | 16.25% |
| 3 | Healthcare | 15.51% |
| 4 | Financials | 12.99% |
| 5 | Communication Services | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Marathon Petroleum
MPC
$55.3B
| $22.7M | 0.02% |
284,130
-20,881
| -7% | -$1.67M |
|
377
Enbridge
ENB
$106B
| $22.5M | 0.02% |
697,847
+526,660
| +308% | +$17M |
|
378
Ovintiv
OVV
$10.8B
| $22.5M | 0.02% |
342,748
+18,003
| +6% | +$1.18M |
|
379
Rio Tinto
RIO
$102B
| $22.4M | 0.02% |
439,950
-759,908
| -63% | -$38.8M |
|
380
Puma Biotechnology
PBYI
$229M
| $22.4M | 0.02% |
488,418
-462,580
| -49% | -$21.2M |
|
381
Patterson-UTI
PTEN
$2.15B
| $22.2M | 0.02% |
1,298,852
-2,375,505
| -65% | -$40.6M |
|
|
ANDV
382
DELISTED
Andeavor
ANDV
| $22.1M | 0.02% |
144,010
-59,419
| -29% | -$9.12M |
|
383
Viatris
VTRS
$11.9B
| $22M | 0.02% |
602,131
-1,065,421
| -64% | -$39M |
|
384
Wingstop
WING
$7.7B
| $21.9M | 0.02% |
320,347
-362
| -0.1% | -$24.7K |
|
385
Verra Mobility
VRRM
$3.97B
| $21.7M | 0.02% |
+2,042,685
| New | +$21.7M |
|
|
CBIO
386
Crescent Biopharma, Inc. Common Stock
CBIO
$178M
| $21.6M | 0.02% |
14,988
-951
| -6% | -$1.37M |
|
387
National Storage Affiliates Trust
NSA
$2.48B
| $21.6M | 0.02% |
847,587
-374
| -0% | -$9.52K |
|
388
Cousins Properties
CUZ
$4.98B
| $21.6M | 0.02% |
606,012
-30,002
| -5% | -$1.07M |
|
389
Range Resources
RRC
$8.3B
| $21.5M | 0.02% |
1,265,619
-1,425
| -0.1% | -$24.2K |
|
390
Diageo
DEO
$57.9B
| $21.2M | 0.02% |
149,865
+1,826
| +1% | +$259K |
|
|
SRE.PRA
391
DELISTED
Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A
SRE.PRA
| $20.9M | 0.02% |
207,392
-733
| -0.4% | -$73.9K |
|
392
Goosehead Insurance
GSHD
$2.05B
| $20.9M | 0.02% |
616,063
-199,447
| -24% | -$6.76M |
|
393
Steel Dynamics
STLD
$19.7B
| $20.7M | 0.02% |
457,981
-33,778
| -7% | -$1.53M |
|
394
Spotify
SPOT
$141B
| $20.6M | 0.02% |
114,051
-51,357
| -31% | -$9.29M |
|
395
First Bancorp
FBNC
$2.29B
| $20.6M | 0.02% |
508,969
+74,434
| +17% | +$3.02M |
|
396
Dollar Tree
DLTR
$20.4B
| $20.6M | 0.02% |
252,197
-748,355
| -75% | -$61M |
|
397
Prestige Consumer Healthcare
PBH
$3.21B
| $20.4M | 0.02% |
538,944
-661
| -0.1% | -$25K |
|
|
ENLK
398
DELISTED
EnLink Midstream Partners, LP
ENLK
| $20.1M | 0.02% |
1,079,890
+646,808
| +149% | +$12.1M |
|
399
Cardlytics
CDLX
$58M
| $20M | 0.02% |
798,499
-7,782
| -1% | -$195K |
|
|
HMHC
400
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $19.9M | 0.02% |
2,836,729
-241,525
| -8% | -$1.69M |
|